The dual nature of specific immunological activity of tumor-derived gp96 preparations

  • Chandawarkar R
  • Wagh M
  • Srivastava P
  • 14


    Mendeley users who have this article in their library.
  • 111


    Citations of this article.


Mice immunized with optimal doses of autologous tumor-derived gp96 resist a challenge with the tumor that was the source of gp96. Immunization with quantities of gp96 5-10 times larger than the optimal dose does not elicit tumor immunity. This lack of effect is shown to be an active, antigen-specific effect, in that immunization with high doses of tumor-derived gp96, but not normal tissue-derived gp96, downregulates the antitumor immune response. Furthermore, immunization with fractionated doses of gp96 elicits the same kind and level of response as elicited by a single dose equivalent to the total of the fractionated doses. This is true of the tumor-protective doses as well as the high downregulatory doses of gp96. The downregulatory activity can be adoptively transferred by CD4(+) but not CD8(+) T lymphocytes from mice immunized with high doses of gp96. These observations indicate that immunization with gp96 induces a highly regulated immune response that, depending upon the conditions of immunization, results in tumor immunity or downregulation.

Author-supplied keywords

  • autoimmunity
  • downregulation
  • heat shock
  • intradermal
  • suppressive t cell

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • R Chandawarkar

  • M Wagh

  • P Srivastava

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free